FDA Approved: SUNITINIB MALATE — Original Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved the original application for sunitinib malate, authorizing a generic version of the cancer drug from NorthStar RxLLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor
• Pancreatic Neuroendocrine Tumor
• Renal Cell Carcinoma

Drugs mentioned

• Sunitinib malate (sunitinib malate)

Snippet

ORIG AP for SUNITINIB MALATE (SUNITINIB MALATE)